Clinical Trials in Hawaii
Here are the 6 most popular medical studies in Hawaii Clinical Trials
Tyrosine Kinase Inhibitor
Ruxolitinib + Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Recruiting1 awardPhase 2
Honolulu, Hawaii
This trial will compare the different tyrosine kinase inhibitors, with and without ruxolitinib, to see how well they work in treating patients with chronic myeloid leukemia.
Behavioral Intervention
Internet-based Pain Management Program for Cancer Survivors
Recruiting1 award17 criteria
Honolulu, Hawaii
This trial is testing whether an online pain coping skills program, plus enhanced usual care, can help improve cancer survivors' pain severity and pain interference more than just enhanced usual care alone.
Popular filter options for Hawaii Clinical Trials trials
Phase 3 Clinical Trials
View 100 phase 3 medical studies.
Bi-specific T-Cell Engager
Steroids + Tyrosine Kinase Inhibitors for Acute Lymphoblastic Leukemia
Recruiting2 awardsPhase 3
Honolulu, Hawaii
This trial is testing if adding the drug blinatumomab to the usual chemotherapy and steroids treatment for acute lymphoblastic leukemia (ALL) is more effective than the standard of care.
Monoclonal Antibodies
Atezolizumab + Usual Therapy for HER2-Positive Metastatic Breast Cancer
Recruiting1 awardPhase 3
South San Francisco, California
This trial is studying how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic).
Monoclonal Antibodies
Immunotherapy + Chemotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
South San Francisco, California
This trial is testing the addition of the immunotherapy drug pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer.
Clinical Trials With No Placebo
View 100 medical studies that do not have a placebo group.
Behavioural Intervention
Project PEER: Understanding the Lung Cancer Patient ExperiEnce
Recruiting1 award
Honolulu, Hawaii
This trial seeks to learn how treatments for lung cancer affect quality of life. Join by emailing study team to get access to the study website & get an e-gift card each month for 12 months for completing surveys. #LungCancer #Participation #ResearchStudy
Bi-specific T-Cell Engager
Steroids + Tyrosine Kinase Inhibitors for Acute Lymphoblastic Leukemia
Recruiting2 awardsPhase 3
Honolulu, Hawaii
This trial is testing if adding the drug blinatumomab to the usual chemotherapy and steroids treatment for acute lymphoblastic leukemia (ALL) is more effective than the standard of care.
View More Hawaii Clinical Trials Trials
See another 84 many medical studies focused on Hawaii Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.